Marcio Souza - 29 Jul 2024 Form 4 Insider Report for Praxis Precision Medicines, Inc. (PRAX)

Role
Chief Executive Officer, Director
Signature
/s/ Alex Nemiroff, as Attorney-in-Fact
Issuer symbol
PRAX
Transactions as of
29 Jul 2024
Net transactions value
$0
Form type
4
Filing time
31 Jul 2024, 21:03:04 UTC
Previous filing
20 May 2024
Next filing
08 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRAX Stock Option (Right to Buy) Award $0 +185,000 $0.000000 185,000 29 Jul 2024 Common Stock 185,000 $56.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this stock option vested as to 7/48ths on July 29, 2024 and the remaining shares vest in substantially equal monthly installments over the following 41 months, subject to the reporting person's continued service through each vesting date.